Artemis Medicare Reports Mixed Q4 Results: Profit Surges Despite EBITDA Decline

Artemis Medicare Services , a prominent healthcare provider, has released its financial results for the fourth quarter of the fiscal year, revealing a mixed performance with notable growth in profit despite a decline in EBITDA.

Revenue Growth and Profit Surge

The company reported a consolidated revenue of ₹239.00 crore for Q4, marking a 6.22% increase from ₹225.00 crore in the same quarter of the previous year. This growth in revenue demonstrates the company's ability to expand its operations and attract more patients.

More impressively, Artemis Medicare's consolidated net profit saw a substantial rise, reaching ₹230.00 crore, up from ₹142.00 crore in the corresponding quarter of the previous year. This represents a remarkable 62.00% year-over-year increase in net profit, highlighting the company's improved profitability and operational efficiency.

EBITDA and Margin Contraction

Despite the strong revenue and profit growth, Artemis Medicare experienced a decline in its EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). The EBITDA for Q4 stood at ₹359.00 crore, down from ₹380.00 crore in the same quarter last year, representing a 5.53% decrease.

Consequently, the EBITDA margin contracted to 14.96% from 16.85% in the year-ago period. This margin compression suggests that the company faced some challenges in managing its operational costs during the quarter.

Quarterly Performance Analysis

Looking at the quarterly trend, Artemis Medicare showed some fluctuations in its performance:

The quarter-on-quarter comparison reveals a slight decline across key financial metrics. However, it's important to note that the healthcare sector often experiences seasonal fluctuations, and a single quarter's performance may not reflect the overall trend.

Annual Performance Highlights

For the full fiscal year, Artemis Medicare demonstrated strong growth:

• Annual revenue reached ₹885.90 crore, up 18.94% from the previous year's ₹744.80 crore.
• EBITDA for the year stood at ₹140.10 crore, showing a significant increase of 38.30% year-over-year.
• The company's net profit for the fiscal year was ₹49.10 crore, representing a 29.21% growth compared to the previous year.

Conclusion

Artemis Medicare's Q4 results present a nuanced picture of the company's performance. While the substantial increase in net profit and revenue growth are positive indicators, the decline in EBITDA and margin contraction suggest that the company may need to focus on cost management in the coming quarters. The overall annual performance, however, remains strong, indicating that Artemis Medicare continues to strengthen its position in the healthcare sector.